228 related articles for article (PubMed ID: 2426934)
21. Plasma beta-thromboglobulin as a measure of platelet activity. Effect of risk factors and findings in ischemic heart disease and after acute myocardial infarction.
Pumphrey CW; Dawes J
Am J Cardiol; 1982 Dec; 50(6):1258-61. PubMed ID: 6183969
[TBL] [Abstract][Full Text] [Related]
22. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
Ireland HA; Boisclair MD; Lane DA; Thompson E; Curtis JR
Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
[TBL] [Abstract][Full Text] [Related]
23. Does exercise-induced myocardial ischaemia cause enhanced platelet activation and fibrin formation in patients with stable angina and severe coronary artery disease?
Gallino A; Häberli A; Straub PW; Steinbrunn W; Turina M; Rothlin ME
Eur Heart J; 1987 Jul; 8(7):734-7. PubMed ID: 2958280
[TBL] [Abstract][Full Text] [Related]
24. Plasma beta-thromboglobulin and platelet factor 4 in patients with chronic renal failure and effect of hemodialysis.
Endo Y; Mamiya S; Satoh M; Takahashi K; Harada T
Tohoku J Exp Med; 1981 Dec; 135(4):349-58. PubMed ID: 6175048
[TBL] [Abstract][Full Text] [Related]
25. Plasma concentrations of platelet-specific proteins in young female acute myocardial infarction survivors and their age-matched female controls.
Kutti J; Johansson S; Eriksson KA; Sigvaldason A; Vedin A; Wadenvik H; Wilhelmsson C
Eur Heart J; 1983 May; 4(5):300-5. PubMed ID: 6193960
[TBL] [Abstract][Full Text] [Related]
26. Beta-thromboglobulin and fibrinopeptide A in diabetes mellitus as markers of vascular damage.
Librenti MC; D'Angelo A; Micossi P; Garimberti B; Mannucci PM; Pozza G
Acta Diabetol Lat; 1985; 22(1):39-45. PubMed ID: 2408434
[TBL] [Abstract][Full Text] [Related]
27. Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formation.
Lane DA; Ireland H; Flynn A; Anastassiades E; Curtis JR
Nephrol Dial Transplant; 1986; 1(3):179-87. PubMed ID: 2955253
[TBL] [Abstract][Full Text] [Related]
28. Heparin-releasable platelet factor 4 in patients with coronary artery disease.
Sadayasu T; Nakashima Y; Yashiro A; Kawashima T; Kuroiwa A
Clin Cardiol; 1991 Sep; 14(9):725-9. PubMed ID: 1835913
[TBL] [Abstract][Full Text] [Related]
29. Fibrinopeptide A, beta-thromboglobulin, and fibrin degradation products as screening test for the diagnosis of deep vein thrombosis.
Wojciechowski J; Olausson M; Korsan-Bengtsen K
Haemostasis; 1983; 13(4):254-61. PubMed ID: 6194049
[TBL] [Abstract][Full Text] [Related]
30. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease.
Hughes RD; Lane DA; Ireland H; Langley PG; Gimson AE; Williams R
Clin Sci (Lond); 1985 Jun; 68(6):701-7. PubMed ID: 2485273
[TBL] [Abstract][Full Text] [Related]
31. Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina.
Mombelli G; Marchetti O; Haeberli A; Straub PW
Am Heart J; 1998 Dec; 136(6):1106-13. PubMed ID: 9842027
[TBL] [Abstract][Full Text] [Related]
32. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
[TBL] [Abstract][Full Text] [Related]
33. Platelet factor 4 (PF4) and heparin-released platelet factor 4 (HR-PF4) in patients with cardiovascular disorders.
Cella G; Colby SI; Taylor AD; McCracken L; Parisi AF; Sasahara AA
Thromb Res; 1983 Mar; 29(5):499-509. PubMed ID: 6222505
[TBL] [Abstract][Full Text] [Related]
34. The effects of three different heparin regimes on heparin concentrations in plasma and fibrin formation in dialyzers.
Gunnarsson B; Asaba H; Dawidson S; Wilhelmsson S; Bergström J
Clin Nephrol; 1981 Mar; 15(3):135-42. PubMed ID: 7273488
[TBL] [Abstract][Full Text] [Related]
35. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
Cadroy Y; Horbett TA; Hanson SR
J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
[TBL] [Abstract][Full Text] [Related]
36. beta-Thromboglobulin in acute myocardial infarction.
Rasi V; Torstila I; Ikkala E
Acta Med Scand Suppl; 1980; 642():85-91. PubMed ID: 6161525
[TBL] [Abstract][Full Text] [Related]
37. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
[TBL] [Abstract][Full Text] [Related]
38. Fibrin formation and platelet activation in patients with myocardial infarction and normal coronary arteries.
Rapold HJ; Haeberli A; Kuemmerli H; Weiss M; Baur HR; Straub WP
Eur Heart J; 1989 Apr; 10(4):323-33. PubMed ID: 2524385
[TBL] [Abstract][Full Text] [Related]
39. Elevated thrombotic activity after myocardial infarction: A 2-year follow-up study.
Martínez-Sales V; Vila V; Réganon E; Goberna MA; Ferrando F; Palencia MA; Aznar J
Haemostasis; 1998; 28(6):301-6. PubMed ID: 10461012
[TBL] [Abstract][Full Text] [Related]
40. Characterization of platelet activation and thrombin generation accompanying percutaneous transluminal coronary angioplasty.
Vaitkus PT; Watkins MW; Witmer WT; Tracy RP; Sobel BE
Coron Artery Dis; 1995 Jul; 6(7):587-92. PubMed ID: 7582198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
